U.S. undefined Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Biotechnology
Y-mAbs Therapeutics Inc (YMAB) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and Strategic Expansions
Despite a dip in quarterly revenues, Y-mAbs Therapeutics Inc (YMAB) focuses on strategic growth with new partnerships and patent extensions. 17 hours ago
Media - Diversified
Saga Communications Inc (SGA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges Amid Strategic Growth
Saga Communications Inc (SGA) reports a mixed quarter with revenue declines but strong growth in e-commerce and interactive segments. 17 hours ago
Retail - Cyclical
a.k.a. Brands Holding Corp (AKA) Q3 2024 Earnings Call Highlights: Strong U.S. Sales and Record Gross Margin Propel Growth
Despite challenges in international markets, a.k.a. Brands Holding Corp (AKA) reports robust financial performance and strategic expansion initiatives. 17 hours ago
Telecommunication Services
Globalstar Inc (GSAT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advances
Globalstar Inc (GSAT) reports a 25% revenue increase, strategic service extensions, and enhanced satellite capabilities in its Q3 2024 earnings call. 17 hours ago
Manufacturing - Apparel & Accessories
Hanesbrands Inc (HBI) Q3 2024 Earnings Call Highlights: Strong Profit Growth Amid Sales Challenges
Despite a decline in revenue, Hanesbrands Inc (HBI) reports significant profit increases and debt reduction, raising its outlook for the year. 17 hours ago
Medical Devices & Instruments
Apyx Medical Corp (APYX) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Restructuring and Innovation
Despite a revenue dip, Apyx Medical Corp (APYX) focuses on growth through new product development and strategic investments. 17 hours ago
Transportation
L.B. Foster Co (FSTR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Growth and Profitability
Despite a dip in revenue, L.B. Foster Co (FSTR) achieves record gross margins and strengthens its financial position through strategic initiatives. 17 hours ago
Biotechnology
Cartesian Therapeutics Inc (RNAC) Reports Q3 2024 EPS of $(1.13), Revenue of $387K, Missing Analyst Estimates
Biopharmaceutical Company Faces Challenges Amidst Clinical Advancements 19 hours ago
Biotechnology
Q32 Bio Inc Reports Q3 2024 Net Loss of $1.46 Per Share with Revenue Focus on Clinical Progress
Clinical Trials Progress and Financial Overview 19 hours ago
Drug Manufacturers
ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance Amid Challenges
ANI Pharmaceuticals Inc (ANIP) reports a 13% revenue increase and raises full-year guidance, driven by Cortrophin Gel demand and strategic acquisitions. 19 hours ago
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers